Year-long price target forecasts from three prominent analysts have recently been released for Alibaba Health Information Technology, with an average price target of HK$4.62. This potential gain of 45.28 percent from the previous closing price in May, 2024 is calculated on a high forecast of HK$8.88 and a low estimate of HK$3.69. Even if you are not interested in 241 stock, you should still be aware of its competitors.

HK$4.62

45.28% Upside

Outperform

Alibaba Health Information Technology Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Alibaba Health Information Technology's Price has decreased from HK$0.30 to HK$0.00 – a 100.00% drop. In the next year, analysts expect Fair Value to reach HK$0.00 – an increase of 100.00%. For the next five years, the forecast is for Fair Value to grow by 100.00%.

2026 Fair Value Forecast

HK$0.00

2027 Fair Value Forecast

HK$0.00

2028 Fair Value Forecast

HK$0.00

2029 Fair Value Forecast

HK$0.00

2030 Fair Value Forecast

HK$0.00

Alibaba Health Information Technology Revenue Forecast for 2023 - 2025 - 2030

Alibaba Health Information Technology's Revenue has increased by 178.88% In the last three years, going from HK$9.60B to HK$26.76B. For the following year, the 0 analysts predict that Alibaba Health Information Technology's Revenue will drop by 28.62%, reaching HK$19.10B. In 2030, the professionals' prediction is that 241's Revenue will decrease by 24.42%, reaching HK$20.23B.

2024 Rev Forecast

HK$19.10B

2025 Rev Forecast

HK$18.62B

2026 Rev Forecast

HK$19.84B

2027 Rev Forecast

HK$22.25B

2028 Rev Forecast

HK$21.19B

2029 Rev Forecast

HK$20.34B

2030 Rev Forecast

HK$20.23B

Alibaba Health Information Technology Dividend per Share Forecast for 2023 - 2025 - 2030

Alibaba Health Information Technology Free Cash Flow Forecast for 2023 - 2025 - 2030

Alibaba Health Information Technology EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Alibaba Health Information Technology has seen a decline in its EBITDA, from HK$-53.03M to HK$-24.48M – a 53.84% decrease. Next year, analysts are expecting EBITDA to reach HK$-367.06M – an increase of 1399.42%. Over the next seven years, the forecast is for EBITDA to grow by 2979923.56%.

2024 EBITDA Forecast

HK$-367058016.00

2025 EBITDA Forecast

HK$-5639320299.35

2026 EBITDA Forecast

HK$-82913986474.63

2027 EBITDA Forecast

HK$-5522071499.21

2028 EBITDA Forecast

HK$-27882963759.06

2029 EBITDA Forecast

HK$-142026523067.42

2030 EBITDA Forecast

HK$-729509767300.92

Alibaba Health Information Technology EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Alibaba Health Information Technology's EBIT has decreased by 23.61%, from HK$-67.42M to HK$-51.50M. For next year, analysts predict EBIT of HK$-369.11M, which would mean an increase of 616.73%. Over the next seven years, experts predict that Alibaba Health Information Technology's EBIT will grow at a rate of 100089.91%.

2024 EBIT Forecast

HK$-369114233.33

2025 EBIT Forecast

HK$-2891542473.47

2026 EBIT Forecast

HK$-20815154034.28

2027 EBIT Forecast

HK$-2817678017.77

2028 EBIT Forecast

HK$-7188741926.75

2029 EBIT Forecast

HK$-18973965441.45

2030 EBIT Forecast

HK$-51597801621.48

Alibaba Health Information Technology EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Alibaba Health Information Technology's EPS has decreased from HK$0.02 to HK$0.00 – a 100.00% drop. In the next year, analysts expect EPS to reach HK$0.00 – an increase of 100.00%. For the next five years, the forecast is for EPS to grow by 100.00%.

2026 EPS Forecast

HK$0.00

2027 EPS Forecast

HK$0.00

2028 EPS Forecast

HK$0.00

2029 EPS Forecast

HK$0.00

2030 EPS Forecast

HK$0.00